A. Salapatek
Publications by Year
Research Areas
Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, Contact Dermatitis and Allergies, Olfactory and Sensory Function Studies, Food Allergy and Anaphylaxis Research
Most-Cited Works
- → Perspectives in allergen immunotherapy: 2019 and beyond(2019)134 cited
- → Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future – an EAACI Position Paper(2017)95 cited
- → Double‐blind, placebo‐controlled, dose‐ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber(2013)71 cited
- → Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes(2012)28 cited
- → Provocation of nonallergic rhinitis subjects in response to simulated weather conditions using an environmental exposure chamber model(2012)26 cited
- → Ca2+ influx and cAMP elevation overcame botulinum toxin A but not tetanus toxin inhibition of insulin exocytosis(2001)23 cited
- → Persistent Treatment Effect Achieved At One Year After Four Doses Of Der p Derived Synthetic Peptide Immuno-Regulatory Epitopes In An Exposure Chamber Model Of House Dust Mite Allergy(2014)19 cited
- → Mechanism of action of cholecystokinin octapeptide on cat lower esophageal sphincter(1992)14 cited
- → Ectoin®, a Novel, Non-Drug, Extremophile-Based Device, Relieves Allergic Rhinoconjunctivitis Symptoms in Patients in an Environmental Exposure Chamber Model(2011)13 cited
- → Immunotherapy – 2067. FEL d 1 peptide antigen desensitization safety and efficacy in a double-blind, placebo-controlled environmental exposure chamber study(2013)8 cited